Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Review of Anti-Infective Therapy|May 10, 2014
Dosing of antibacterial agents in obese adults: does one size fit all?Kenna D Payne, Ronald G HallExpert Review of Anti-Infective Therapy|December 8, 2015
Dosing of antifungal agents in obese peopleKenna D Payne, Ronald G HallExpert Review of Clinical Pharmacology|December 1, 2017
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options)Kenna D Payne, Amrita Das, Michelle Ndiulor, et al.Expert Review of Clinical Pharmacology|March 16, 2017
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options)Ronald G Hall, Michael Thatcher, Wei Wei, et al.American Journal of Pharmaceutical Education|September 21, 2013
A standardized patient counseling rubric for a pharmaceutical care and communications courseNiambi Horton, Kenna D Payne, Michelle Jernigan, et al.Pharmacotherapy|June 26, 2008
Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapyAnita P Rahman, Susan A Eaton, Sean T Nguyen, et al.The American Journal of Medicine|May 27, 2008
Multicenter evaluation of vancomycin dosing: emphasis on obesityRonald G Hall, Kenna D Payne, Amy M Bain, et al.Pharmacotherapy|February 26, 2008
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virusSean T Nguyen, Susan A Eaton, Amy M Bain, et al.Pageof 1